Kura Oncology
Laura Serra serves as the Executive Director of Medical Affairs Strategy at Kura Oncology, Inc. since August 2025. Prior to this role, Laura accumulated extensive experience at AbbVie, holding various positions including Scientific Director and Team Lead for Oncology US Medical Affairs, as well as Global Director of Oncology Pipeline MSLs within Global Medical Affairs, spanning over 15 years. Laura’s earlier career included roles at Abbott as a Clinical Integration Manager and Medical Science Liaison, and positions as a Research Scientist at Kimberly-Clark and Reig Jofre. Laura's academic background includes a PhD and MS in Pharmaceutical Sciences and a PharmD from Universitat de Barcelona, complemented by a degree in Piano performance from the Professional Conservatory of Music in Badalona.
This person is not in any teams
This person is not in any offices
Kura Oncology
21 followers
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment.